Qichang Fu1, Yuting Wang2, Yi Zhang1, Yong Zhang1, Xinbin Guo3, Haowen Xu3, Zhiqiang Yao3, Meng Wang4, Michael R Levitt5,6,7, Mahmud Mossa-Basha6, Jinxia Zhu8, Jingliang Cheng8, Sheng Guan3, Chengcheng Zhu6,9. 1. Department of Magnetic Resonance (Q.F., Yi Zhang, Yong Zhang, J.C.), The First Affiliated Hospital of Zhengzhou University, Chinar. 2. Department of Radiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu (Y.W.). 3. Department of Interventional Neuroradiology (X.G., H.X., Z.Y., S.G.), The First Affiliated Hospital of Zhengzhou University, Chinar. 4. Department of Neurological Surgery (M.W.), The First Affiliated Hospital of Zhengzhou University, Chinar. 5. Department of Neurological Surgery (M.R.L.), University of Washington, Seattle. 6. Department of Radiology (M.R.L., M.M.-B., C.Z.), University of Washington, Seattle. 7. Department of Mechanical Engineering (M.R.L.), University of Washington, Seattle. 8. MR Collaboration, Siemens Healthcare Ltd, Beijing, China (J.Z.). 9. Department of Radiology and Biomedical Imaging, University of California, San Francisco (C.Z.).
Abstract
BACKGROUND AND PURPOSE: Aneurysmal wall enhancement (AWE) on vessel wall magnetic resonance imaging (VW-MRI) has been described as a new imaging biomarker of unstable unruptured intracranial aneurysms (UIAs). Previous studies of symptomatic UIAs are limited due to small sample sizes and lack of AWE quantification. Our study aims to investigate whether qualitative and quantitative assessment of AWE can differentiate symptomatic and asymptomatic UIAs. METHODS: Consecutive patients with UIAs were prospectively recruited for vessel wall magnetic resonance imaging at 3T from October 2014 to October 2019. UIAs were categorized as symptomatic if presenting with sentinel headache or oculomotor nerve palsy directly related to the aneurysm. Evaluation of wall enhancement included enhancement pattern (0=none, 1=focal, and 2=circumferential) and quantitative wall enhancement index (WEI). Univariate and multivariate analyses were used to identify the parameters associated with symptoms. RESULTS: Two hundred sixty-seven patients with 341 UIAs (93 symptomatic and 248 asymptomatic) were included in this study. Symptomatic UIAs more frequently showed circumferential AWE than asymptomatic UIAs (66.7% versus 17.3%, P<0.001), as well as higher WEI (median [interquartile range], 1.3 [1.0-1.9] versus 0.3 [0.1-0.9], P<0.001). In multivariate analysis, both AWE pattern and WEI were independent factors associated with symptoms (odds ratio=2.03 across AWE patterns [95% CI, 1.21-3.39], P=0.01; odds ratio=3.32 for WEI [95% CI, 1.51-7.26], P=0.003). The combination of AWE pattern and WEI had an area under the curve of 0.91 to identify symptomatic UIAs, with a sensitivity of 95.7% and a specificity of 73.4%. CONCLUSIONS: In a large cohort of UIAs with vessel wall magnetic resonance imaging, both AWE pattern and WEI were independently associated with aneurysm-related symptoms. The qualitative and quantitative features of AWE can potentially be used to identify unstable intracranial aneurysms.
BACKGROUND AND PURPOSE: Aneurysmal wall enhancement (AWE) on vessel wall magnetic resonance imaging (VW-MRI) has been described as a new imaging biomarker of unstable unruptured intracranial aneurysms (UIAs). Previous studies of symptomatic UIAs are limited due to small sample sizes and lack of AWE quantification. Our study aims to investigate whether qualitative and quantitative assessment of AWE can differentiate symptomatic and asymptomatic UIAs. METHODS: Consecutive patients with UIAs were prospectively recruited for vessel wall magnetic resonance imaging at 3T from October 2014 to October 2019. UIAs were categorized as symptomatic if presenting with sentinel headache or oculomotor nerve palsy directly related to the aneurysm. Evaluation of wall enhancement included enhancement pattern (0=none, 1=focal, and 2=circumferential) and quantitative wall enhancement index (WEI). Univariate and multivariate analyses were used to identify the parameters associated with symptoms. RESULTS: Two hundred sixty-seven patients with 341 UIAs (93 symptomatic and 248 asymptomatic) were included in this study. Symptomatic UIAs more frequently showed circumferential AWE than asymptomatic UIAs (66.7% versus 17.3%, P<0.001), as well as higher WEI (median [interquartile range], 1.3 [1.0-1.9] versus 0.3 [0.1-0.9], P<0.001). In multivariate analysis, both AWE pattern and WEI were independent factors associated with symptoms (odds ratio=2.03 across AWE patterns [95% CI, 1.21-3.39], P=0.01; odds ratio=3.32 for WEI [95% CI, 1.51-7.26], P=0.003). The combination of AWE pattern and WEI had an area under the curve of 0.91 to identify symptomatic UIAs, with a sensitivity of 95.7% and a specificity of 73.4%. CONCLUSIONS: In a large cohort of UIAs with vessel wall magnetic resonance imaging, both AWE pattern and WEI were independently associated with aneurysm-related symptoms. The qualitative and quantitative features of AWE can potentially be used to identify unstable intracranial aneurysms.
Entities:
Keywords:
biomarkers; headache; inflammation; intracranial aneurysm; magnetic resonance imaging
Authors: M D I Vergouwen; D Backes; I C van der Schaaf; J Hendrikse; R Kleinloog; A Algra; G J E Rinkel Journal: AJNR Am J Neuroradiol Date: 2019-06-20 Impact factor: 3.825
Authors: M Mossa-Basha; C Zhu; C Yuan; L Saba; D A Saloner; M Edjlali; N V Stence; D M Mandell; J M Romero; Y Qiao; D J Mikulis; B A Wasserman Journal: AJNR Am J Neuroradiol Date: 2022-06-16 Impact factor: 4.966
Authors: Rob Molenberg; Marlien W Aalbers; Auke P A Appelman; Maarten Uyttenboogaart; J Marc C van Dijk Journal: Eur J Neurol Date: 2021-08-25 Impact factor: 6.288
Authors: Adam E Galloy; Ashrita Raghuram; Marco A Nino; Alberto Varon Miller; Ryan Sabotin; Carlos Osorno-Cruz; Edgar A Samaniego; Suresh M L Raghavan; David Hasan Journal: Front Neurol Date: 2021-12-10 Impact factor: 4.003
Authors: Ashrita Raghuram; Alberto Varon; Jorge A Roa; Daizo Ishii; Yongjun Lu; Madhavan L Raghavan; Chaorong Wu; Vincent A Magnotta; David M Hasan; Timothy R Koscik; Edgar A Samaniego Journal: Sci Rep Date: 2021-09-15 Impact factor: 4.379